Episode
Closing the Treatment Gap for Patients Living with Tremor with Deanna Harshbarger, CEO of Cala Health
- Podcast
- Outcomes Rocket
- Published
- Jun 30, 2026
- Duration seconds
- 1036
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/outcomes-rocket-769427/episodes/closing-the-treatment-gap-for-patients-living-with-tremor-with-deanna-harshbarger-ceo-of-cala-health/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/outcomes-rocket-769427/closing-the-treatment-gap-for-patients-living-with-tremor-with-deanna-harshbarger-ceo-of-cala-health.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Many patients with tremor are caught between medications that lose effectiveness and invasive procedures they may not be ready to pursue. In this episode, Deanna Harshbarger, CEO of Cala Health, discusses how non-invasive bioelectronic medicine is creating a new treatment pathway for patients with essential tremor. She explains how Cala’s wearable therapy measures each patient’s tremor, personalizes stimulation, and uses the peripheral nervous system to interrupt tremor-related signals. Deanna also shares how the company overcame regulatory, reimbursement, and access challenges while building an entirely new category of care. Tune in to learn how patient-centered design, perseverance, and personalized neurostimulation are expanding treatment options for people living with tremor. Resources: Connect with and follow Deanna Harshbarger on LinkedIn. Follow Cala Health on LinkedIn and explore their website. Watch the video to learn how Cala Therapy works: https://calahealth.com/product/how-taps-works/